The largest database of trusted experimental protocols

Lipopolysaccharide from e coli o111 b4

Manufactured by Merck Group
Sourced in United States

Lipopolysaccharide from E. coli O111:B4 is a bacterial endotoxin extracted from the cell wall of the Escherichia coli strain O111:B4. It is a complex molecule consisting of a lipid component (lipid A) and a polysaccharide component. This product is typically used for research purposes in the field of immunology and microbiology.

Automatically generated - may contain errors

6 protocols using lipopolysaccharide from e coli o111 b4

1

Differentiation of Murine Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived macrophages were obtained by flushing from murine (OPA1f/f or OPA1M/M) femur and tibia and differentiated into macrophages in RPMI 1640, 10% FBS (Superior, Millipore), Glutamine (300 mg/L), sodium pyruvate (1 mM), 2-mercaptoethanol (0.01 mM), HEPES (25 Mm) in the presence of M-CSF (Miltenyi Biotec), 40 ng/ml for 5 days and then refilled with 2 mL more with M-CSF (20 ng/mL) for 2 more days. At day 7, cells were differentiated to: M1 with Lipopolysaccharide from E. coli O111:B4 (Sigma-Aldrich) (LPS) (500 ng/mL) and IFNγ, 25 ng/mL (Miltenyi Biotec) or M2 with IL-4 (Miltenyi Biotec) 25 ng/mL; for 24 h at 37 °C, 5% CO2. Different treatments were performed blinded to the mouse genotypes.
+ Open protocol
+ Expand
2

Macrophage Activation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals, antibiotics and reagents were used: lipopolysaccharide from E. coli O111: B4 (Sigma, Cat. No L4391); alginic acid (Sigma, Cat. No. A0682); bovine serum albumin (BSA) (Fisher Bioreagents, Cat. No. BP1600); heat-inactivated fetal bovine serum (FBS) (RMBIO, Cat. No. FBS-BHT-5XM); RPMI (HyClone, Cat. No. SH30027.01); penicillin-streptomycin solution (Corning, Cat. No. MT30002CI), sodium pyruvate (HyClone, Cat. No. SH3023901); tryp-tone (Fluka Analytical, Cat. No. T7293); sodium chloride (Acros Organics, Cat. No. 7647–14-5); yeast extract (Boston BioProducts, Cat. No. P-950); agar (Fisher BioReagents, Cat. No. BP9744); gentamicin (Amresco, Cat. No. E737); carbenicillin (Gold Biotechnology, Cat. No. C-103–25); and kanamycin (Fisher BioReagents, Cat. No. BP906).
+ Open protocol
+ Expand
3

Endotoxin and Cytoskeleton Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals were purchased from Sigma Aldrich: Lipopolysaccharide (from E. coli O111:B4), Sigma cat # LPS25; Actinomycin D, Sigma cat # A9415; Cytochalasin D, Sigma cat # C8273.
+ Open protocol
+ Expand
4

Chondrogenic Effects of Polyphenols under Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide from E. coli O111:B4 (Sigma, St. Louis, St. Louis, MO, USA) was dissolved in phosphate-buffered saline at the stock concentration of 1 mg/mL. The cell proliferation screening to determine the optimal LPS concentration for further experiments was performed using MTS assays. Serial dilutions of LPS (1, 0.1, 0.01, 0.001 µg/mL) were added to primary hMSCs from the patients with hip osteoarthritis, which were left for 18 h to simulate inflammatory conditions. After 18 h, the cell medium was changed and the tested polyphenolic extracts and polyphenols were added at 375 mg/mL. The MTS assays were performed as described above. Based on the results of these MTS assays, the optimal concentration of LPS was selected as 0.01 µg/mL for the condition of chondrogenesis under inflammation.
Therefore, micromasses were formed from MSCs derived from the patients with hip osteoarthritis and were pre-treated with 0.01 µg/mL LPS for 18 h to simulate inflammation. Then, the micromasses were treated with the polyphenolic extracts and polyphenols to be tested, and with the addition of TGF-β1, for 7 days. Alcian blue was used to determine chondrogenesis as described above.
+ Open protocol
+ Expand
5

Evaluating LPS and TAK-242 Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide from E. coli O111:B4 was purchased from Sigma‐Aldrich, and TAK‐242 was purchased from Cayman Chemical. VAS2870 was a generous gift from Vasopharm.
+ Open protocol
+ Expand
6

Ovine Placental Response to Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To as sess CHDP ex pres sion in re sponse to in fec tion, an in vitro ovine pla cen tal model was em ployed. AH1 tro phoblast cells were grown to 80% con flu ency overnight in a 24 well plate, and sub se quently ex posed to LPS or in fected with live W. chon drophila. For LPS ex po sures, AH1 cells were treated in du pli cate with LPS (500 ng/ mL, lipopolysac cha ride from E.coli O111:B4, Sigma, L2630-10 mg) which was dis solved in ul tra pure wa ter and stored at -80 °C (n = 4). AH1 cells were also in fected with W. chon drophila at a mul ti plic ity of in fec tion (MOI) of 0.1, 1 and 10 (equiv a lent of 1 in clu sion form ing unit (IFU) per 10 cells, 1 IFU per cell and 10 IFU per cell, re spec tively) or ex posed to UV ir ra di ated or gan isms at MOI 10 (n = 3). Cells were main tained in a heated, hu mid i fied in cu ba tor at 37 °C with 5% CO for 48 h dur ing treat ment. For Vi t a min D ex po sures, 1α,25di hy drox yvi t a min D (cal citriol, Enzo Life Sci ences, Ex eter, United King dom) was dis solved in ab solute al co hol at a stock con cen tra tion of 1 mM and stored at -80 °C. AH1 cells were ex posed to Vi t a min D in du pli cate at con cen tra tions of 1 nM, 10 nM and 100 nM for 24 h and in all treat ments, a ve hi cle con trol was per formed (1 μl/ mL EtOH) (n = 3).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!